Selected research
Industry Research
Epigenetics Services Industry Research Report 2026
Market perspective
The global Epigenetics Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Epigenetics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Epigenetics Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Epigenetics Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Epigenetics Services include Bio-Rad, lllumina, QIAGEN, Thermo Fisher, Active Motif, Diagenode, Agilent, Merck Millipore and Abcam, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Epigenetics Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Epigenetics Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epigenetics Services Market by Company
Bio-Rad
lllumina
QIAGEN
Thermo Fisher
Active Motif
Diagenode
Agilent
Merck Millipore
Abcam
New England Biolabs+
PerkinEImer
Zymo Research
Epigenetics Services Segment by Type
DNA Methylation
Histone Modification
Others
Epigenetics Services Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organization (CRO)
Epigenetics Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epigenetics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Epigenetics Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Methylation
- Histone Modification
- Others
Applications
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organization (CRO)
Companies covered
- Bio-Rad
- lllumina
- QIAGEN
- Thermo Fisher
- Active Motif
- Diagenode
- Agilent
- Merck Millipore
- Abcam
- New England Biolabs+
- PerkinEImer
- Zymo Research
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Epigenetics Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Methylation
- 2.2.3 Histone Modification
- 2.2.4 Others
- 2.3 Epigenetics Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic and Research Institutes
- 2.3.3 Pharmaceutical and Biotechnology Companies
- 2.3.4 Contract Research Organization (CRO)
- 2.4 Assumptions and Limitations
3 Epigenetics Services Breakdown Data by Type
- 3.1 Global Epigenetics Services Historic Market Size by Type (2021-2026)
- 3.2 Global Epigenetics Services Forecasted Market Size by Type (2027-2032)
4 Epigenetics Services Breakdown Data by Application
- 4.1 Global Epigenetics Services Historic Market Size by Application (2021-2026)
- 4.2 Global Epigenetics Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Epigenetics Services Market Perspective (2021-2032)
- 5.2 Global Epigenetics Services Growth Trends by Region
- 5.2.1 Global Epigenetics Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Epigenetics Services Historic Market Size by Region (2021-2026)
- 5.2.3 Epigenetics Services Forecasted Market Size by Region (2027-2032)
- 5.3 Epigenetics Services Market Dynamics
- 5.3.1 Epigenetics Services Industry Trends
- 5.3.2 Epigenetics Services Market Drivers
- 5.3.3 Epigenetics Services Market Challenges
- 5.3.4 Epigenetics Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Epigenetics Services Players by Revenue
- 6.1.1 Global Top Epigenetics Services Players by Revenue (2021-2026)
- 6.1.2 Global Epigenetics Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Epigenetics Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Epigenetics Services Head Office and Area Served
- 6.4 Global Epigenetics Services Players, Product Type & Application
- 6.5 Global Epigenetics Services Manufacturers Established Date
- 6.6 Global Epigenetics Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Epigenetics Services Market Size (2021-2032)
- 7.2 North America Epigenetics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Epigenetics Services Market Size by Country (2021-2026)
- 7.4 North America Epigenetics Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Epigenetics Services Market Size (2021-2032)
- 8.2 Europe Epigenetics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Epigenetics Services Market Size by Country (2021-2026)
- 8.4 Europe Epigenetics Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Epigenetics Services Market Size (2021-2032)
- 9.2 Asia-Pacific Epigenetics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Epigenetics Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Epigenetics Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Epigenetics Services Market Size (2021-2032)
- 10.2 South America Epigenetics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Epigenetics Services Market Size by Country (2021-2026)
- 10.4 South America Epigenetics Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Epigenetics Services Market Size (2021-2032)
- 11.2 Middle East & Africa Epigenetics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Epigenetics Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Epigenetics Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bio-Rad
- 12.1.1 Bio-Rad Company Information
- 12.1.2 Bio-Rad Business Overview
- 12.1.3 Bio-Rad Revenue in Epigenetics Services Business (2021-2026)
- 12.1.4 Bio-Rad Epigenetics Services Product Portfolio
- 12.1.5 Bio-Rad Recent Developments
- 12.2 lllumina
- 12.2.1 lllumina Company Information
- 12.2.2 lllumina Business Overview
- 12.2.3 lllumina Revenue in Epigenetics Services Business (2021-2026)
- 12.2.4 lllumina Epigenetics Services Product Portfolio
- 12.2.5 lllumina Recent Developments
- 12.3 QIAGEN
- 12.3.1 QIAGEN Company Information
- 12.3.2 QIAGEN Business Overview
- 12.3.3 QIAGEN Revenue in Epigenetics Services Business (2021-2026)
- 12.3.4 QIAGEN Epigenetics Services Product Portfolio
- 12.3.5 QIAGEN Recent Developments
- 12.4 Thermo Fisher
- 12.4.1 Thermo Fisher Company Information
- 12.4.2 Thermo Fisher Business Overview
- 12.4.3 Thermo Fisher Revenue in Epigenetics Services Business (2021-2026)
- 12.4.4 Thermo Fisher Epigenetics Services Product Portfolio
- 12.4.5 Thermo Fisher Recent Developments
- 12.5 Active Motif
- 12.5.1 Active Motif Company Information
- 12.5.2 Active Motif Business Overview
- 12.5.3 Active Motif Revenue in Epigenetics Services Business (2021-2026)
- 12.5.4 Active Motif Epigenetics Services Product Portfolio
- 12.5.5 Active Motif Recent Developments
- 12.6 Diagenode
- 12.6.1 Diagenode Company Information
- 12.6.2 Diagenode Business Overview
- 12.6.3 Diagenode Revenue in Epigenetics Services Business (2021-2026)
- 12.6.4 Diagenode Epigenetics Services Product Portfolio
- 12.6.5 Diagenode Recent Developments
- 12.7 Agilent
- 12.7.1 Agilent Company Information
- 12.7.2 Agilent Business Overview
- 12.7.3 Agilent Revenue in Epigenetics Services Business (2021-2026)
- 12.7.4 Agilent Epigenetics Services Product Portfolio
- 12.7.5 Agilent Recent Developments
- 12.8 Merck Millipore
- 12.8.1 Merck Millipore Company Information
- 12.8.2 Merck Millipore Business Overview
- 12.8.3 Merck Millipore Revenue in Epigenetics Services Business (2021-2026)
- 12.8.4 Merck Millipore Epigenetics Services Product Portfolio
- 12.8.5 Merck Millipore Recent Developments
- 12.9 Abcam
- 12.9.1 Abcam Company Information
- 12.9.2 Abcam Business Overview
- 12.9.3 Abcam Revenue in Epigenetics Services Business (2021-2026)
- 12.9.4 Abcam Epigenetics Services Product Portfolio
- 12.9.5 Abcam Recent Developments
- 12.10 New England Biolabs+
- 12.10.1 New England Biolabs+ Company Information
- 12.10.2 New England Biolabs+ Business Overview
- 12.10.3 New England Biolabs+ Revenue in Epigenetics Services Business (2021-2026)
- 12.10.4 New England Biolabs+ Epigenetics Services Product Portfolio
- 12.10.5 New England Biolabs+ Recent Developments
- 12.11 PerkinEImer
- 12.11.1 PerkinEImer Company Information
- 12.11.2 PerkinEImer Business Overview
- 12.11.3 PerkinEImer Revenue in Epigenetics Services Business (2021-2026)
- 12.11.4 PerkinEImer Epigenetics Services Product Portfolio
- 12.11.5 PerkinEImer Recent Developments
- 12.12 Zymo Research
- 12.12.1 Zymo Research Company Information
- 12.12.2 Zymo Research Business Overview
- 12.12.3 Zymo Research Revenue in Epigenetics Services Business (2021-2026)
- 12.12.4 Zymo Research Epigenetics Services Product Portfolio
- 12.12.5 Zymo Research Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst